Annexon

$0.00 (0.00%) As of 12:54 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annexon and other ETFs, options, and stocks.

About ANNX

Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy.

CEO
Douglas Love
Employees
61
Headquarters
Brisbane, California
Founded
2011

ANNX Key Statistics

Market cap
134.31M
Price-Earnings ratio
—
Dividend yield
—
Average volume
575.79K
High today
$3.49
Low today
$3.25
Open price
$3.34
Volume
249.46K
52 Week high
$24.85
52 Week low
$2.06

ANNX Earnings

-$0.97
-$0.65
-$0.32
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.92 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure